Changes in glycoprotein fucosylation in a concanavalin A-resistant variant of a human leukemia cell line (K562)
β Scribed by Louise G. Bernier; Arthur K. Sullivan
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 655 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
β¦ Synopsis
Previous studies from this and other laboratories have shown that variants of tumor cell lines can be selected for resistance to the lytic action of natural killer (NK) cells. One of these (K562-Clonc I), when made resistant to the toxic effccts of Concanavalin A (Con A-Rl), regained its sensitivity to NK. Comparing the plasma membrdncs of Clone I and Con A-RI , we observed 1) a very similar electrophoretic pattern of membrane glycoproteins identified by binding to the lectins Con A, WGA, PNA, and SBA; 2) an increase in binding of Ulex europaeus lectin to a group of glycoproteins from Con A-Rl that wcre sensitive to treatment with fucosidase and Nglycanasc and that had a diffuse mobility ranging in apparent molecular weight from 30 to 200 kDa; and 3) a marked decrease in binding of an antibody reactive with the lactoncofucopentaose I11 antigen (Lewis x). This constellation of changes is an unusual pattern to follow Con A resistancc and may point to a pathway of glycosylation that a leukemic cell might use to modify its recognition by the NK mechanism.
π SIMILAR VOLUMES
## Abstract Daughter cells arising from a single cell division in the leukemic cell line K562 have equivalent selfβrenewal potential with respect to their ability to form clones in semisolid medium. However, individual cells isolated from these clones in sequence have vastly different abilities in
An established gastric-carcinoma cell line, EPG85-257P, is extremely sensitive to mitoxantrone (IC 50 , 0.12 ng/ml). Stepwise selection with mitoxantrone for 3 years resulted in a cell line (EPG85-257RN) that is 7,056-fold resistant to mitoxantrone (IC 50 , 846 ng/ml) and displays cross-resistance t
## Abstract We studied the restoration of doxorubicin accumulation and sensitivity by verapamil and quinine in a variant of the human erythroleukemia cell line K562 selected for resistance to doxorubicin and presenting a multidrugβresistance (MDR) phenotype. Verapamil was able to completely restore